John Curnutte
Director/Board Member at PLIANT THERAPEUTICS, INC.
Net worth: 347 823 $ as of 29/04/2024
John Curnutte active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. | Director/Board Member | 31/07/2017 | - |
| Independent Dir/Board Member | 31/07/2017 | - |
Career history of John Curnutte
Former positions of John Curnutte
| Companies | Position | Start | End |
|---|---|---|---|
| ORCHARD THERAPEUTICS PLC | Director/Board Member | 29/08/2019 | 23/01/2024 |
| Independent Dir/Board Member | 29/08/2019 | 23/01/2024 | |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/07/2018 | 16/05/2019 |
| President | 03/06/2018 | 31/07/2018 | |
| DIADEXUS, INC. | Director/Board Member | 23/02/2015 | 31/05/2016 |
| Independent Dir/Board Member | 23/02/2015 | 31/05/2016 | |
| Stanford University School of Medicine | Corporate Officer/Principal | 31/12/1992 | 31/12/2012 |
| SAGIMET BIOSCIENCES INC. | Chief Executive Officer | 31/12/2006 | 28/02/2010 |
| Founder | 31/12/2006 | 28/02/2010 | |
| SAGIMET BIOSCIENCES INC. | Chief Executive Officer | 30/04/2008 | 31/01/2010 |
Schering-Plough Biopharma
 Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | President | 31/08/2000 | 30/04/2008 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Director/Board Member | 31/12/1999 | 31/07/2000 |
| ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Training of John Curnutte
| Harvard University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistics
International
| United States | 12 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SAGIMET BIOSCIENCES INC. | Health Technology |
| PLIANT THERAPEUTICS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Schering-Plough Biopharma
Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | Commercial Services |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Finance |
- Stock Market
- Insiders
- John Curnutte
- Experience